0001179110-18-011382.txt : 20180913 0001179110-18-011382.hdr.sgml : 20180913 20180913181032 ACCESSION NUMBER: 0001179110-18-011382 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180911 FILED AS OF DATE: 20180913 DATE AS OF CHANGE: 20180913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chapman Steven Leonard CENTRAL INDEX KEY: 0001711968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 181069758 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 edgar.xml FORM 4 - X0306 4 2018-09-11 0 0001604821 Natera, Inc. NTRA 0001711968 Chapman Steven Leonard C/O NATERA, INC., 201 INDUSTRIAL ROAD SUITE 410 SAN CARLOS CA 94070 0 1 0 0 Chief Operating Officer Common Stock 2018-09-11 4 M 0 13421 2.6569 A 16628 D Common Stock 2018-09-11 4 M 0 10225 3.7816 A 26853 D Common Stock 2018-09-11 4 M 0 5377 7.4491 A 32230 D Common Stock 2018-09-11 4 M 0 4474 2.6569 A 36704 D Common Stock 2018-09-11 4 M 0 11503 3.7816 A 48207 D Common Stock 2018-09-11 4 S 0 44500 25.1548 D 3707 D Common Stock 2018-09-11 4 S 0 500 25.61 D 3207 D Stock Option (right to buy) 2.6569 2018-09-11 4 M 0 13241 0 D 2024-02-24 Common Stock 13421 0 D Stock Option (right to buy) 3.7816 2018-09-11 4 M 0 10225 0 D 2024-09-17 Common Stock 10225 0 D Stock Option (right to buy) 7.4491 2018-09-11 4 M 0 5377 0 D 2025-03-25 Common Stock 5377 20505 D Stock Option (right to buy) 2.6569 2018-09-11 4 M 0 4474 0 D 2024-02-24 Common Stock 4474 0 D Stock Option (right to buy) 3.7816 2018-09-11 4 M 0 11503 0 D 2024-09-17 Common Stock 11503 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.59 to $25.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The options are 100% vested and exercisable. The option shares vest over four years. 25% of the option shares vest and become exercisable on February 16, 2016 and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Tami Chen, attorney-in-fact 2018-09-12